Biotechnology companies praised a bill introduced in Congress Tuesday that would preserve the period under which they can exclusively sell...
Pharmaceutical giant Pfizer Inc. (PFE) sold its $13.5 billion, multi-part offering in the U.S. corporate bond market to help fund its $68 billion...
Pharmaceutical giant Pfizer Inc. (PFE) launched its $13.5 billion, multi-part offering in the U.S. corporate bond market to help fund its $68...
By Nick Godt As a spree in mergers and acquisitions in the health-care industry showed last week, many companies have cautiously built up cash...
Swiss drug maker Roche Holding AG (ROG.VX) said Monday it has signed a definite agreement under which Roche will acquire 100% of innovatis, a...
Genentech Inc.'s (DNA) ability to leverage a higher price tag from Roche Holding AG (RHHBY) in an otherwise downtrodden market demonstrates the...
Even if U.S. antitrust regulators are worried about consolidation in the pharmaceutical industry, they may have a tough time making a case against...
Gilead Sciences Inc. said Thursday it will acquire CV Therapeutics Inc. for $1.4 billion, the latest in a recent flurry of drug-industry mergers...
Swiss drugmaker Roche Holding AG (ROG.VX) said Thursday it sealed a friendly deal with Genentech Inc. (DNA) to buy the 44% of the U.S. biotech...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.